Table 5.
Significance of the incremental values of selected lipids over the re-estimated minimal risk tool (reMRT) and the two alternative baseline models for the purpose of sensitivity analysis.
Lipid species | LRT-p value | ||
---|---|---|---|
reMRT | Basic model | Basic-hs-cTnT model | |
Cer(d18:1/16:0) | 0.01 | 0.01 | 0.02 |
TG(52:2) | 0.41 | 0.36 | 0.89 |
TG(52:3) | 0.49 | 0.54 | 0.83 |
TG(54:2) | 0.76 | 0.25 | 0.92 |
TG(54:3) | 0.50 | 0.33 | 0.57 |
SM(34:1) | 0.12 | 0.003 | 0.01 |
SM(36:2) | 0.30 | 0.34 | 0.17 |
SM(38:2) | 0.16 | 0.09 | 0.03 |
SM(40:3) | 0.88 | 0.15 | 0.12 |
SM(40:2) | 0.04 | 0.006 | 0.001 |
SM(41:2) | 0.18 | 0.03 | 0.01 |
SM(41:1) | 0.052 | 0.054 | 0.005 |
SM(42:4) | 0.77 | 0.17 | 0.03 |
SM(42:3) | 0.76 | 0.24 | 0.10 |
The p-value of the likelihood ratio test (LRT) is reported for the reMRT model, including age, sex, smoking, diabetes, and hypertension; the basic model, including age, sex, and symptoms; and the basic-hs-cTnT (high-sensitive cardiac troponin T) model, including age, sex, symptoms, and high-sensitive cardiac troponin T (hs-cTnT). Bold charcter highlight significant incremental values.